ACM
AMED

Argent Capital Management’s Amedisys AMED Stock Holding History

Argent Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,925
Closed -$1.15M – 147
2022
Q3 		$1.15M Buy
11,925
+845
+8% +$101K 0.05% 102
2022
Q2 		$1.17M Sell
11,080
-235
-2% -$30K 0.04% 101
2022
Q1 		$1.95M Buy
11,315
+718
+7% +$107K 0.06% 92
2021
Q4 		$1.72M Buy
10,597
+280
+3% +$45K 0.05% 96
2021
Q3 		$1.54M Sell
10,317
-337
-3% -$70.1K 0.05% 99
2021
Q2 		$2.61M Buy
10,654
+578
+6% +$152K 0.08% 83
2021
Q1 		$2.67M Buy
10,076
+37
+0.4% +$10.4K 0.09% 79
2020
Q4 		$2.94M Buy
10,039
+1,173
+13% +$301K 0.1% 71
2020
Q3 		$2.1M Buy
8,866
+946
+12% +$215K 0.08% 76
2020
Q2 		$1.57M Sell
7,920
-4,930
-38% -$920K 0.07% 85
2020
Q1 		$2.36M Buy
12,850
+501
+4% +$89.1K 0.11% 63
2019
Q4 		$2.06M Buy
12,349
+240
+2% +$35.7K 0.07% 111
2019
Q3 		$1.59M Buy
12,109
+159
+1% +$20.7K 0.06% 118
2019
Q2 		$1.45M Buy
11,950
+35
+0.3% +$4.15K 0.06% 124
2019
Q1 		$1.47M Sell
11,915
-98
-0.8% -$12.3K 0.05% 122
2018
Q4 		$1.41M Buy
12,013
+34
+0.3% +$4.01K 0.07% 109
2018
Q3 		$1.5M Buy
11,979
+1,103
+10% +$122K 0.05% 124
2018
Q2 		$929K Buy
+10,876
New +$799K 0.03% 144

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Argent Capital Management's AMED Position: Q4 2022 in Review

Argent Capital Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 11,925 shares — an estimated $1.15M sold.

Argent Capital Management first reported a position in AMED in Q2 2018 and held it in 18 quarters. The position peaked at $2.94M in Q4 2020. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Argent Capital Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Argent Capital Management sold 11,925 Amedisys shares in Q4 2022, an estimated $1.15M.
  • Argent Capital Management first reported a position in Amedisys in Q2 2018 and held it in 18 quarters.
  • Argent Capital Management's Amedisys position peaked at $2.94M in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Argent Capital Management's 13F filing for Q4 2022, filed 3 Feb 2023.